Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Valance OD Compact CSM Quiz

Total questions: 20

Worksheet time: 13mins

Name
Class
Date
1.

Valance OD Compact technology alters the release pattern

a)

True

b)

False

2.

Small size tablet is preferred by_______% of patients

a)

61.1

b)

61.2

c)

61.3

d)

61.4

3.

Deglutition means

a)

Process of regurgitation

b)

Process of dissolving

c)

Process of Swallowing

d)

Process of release

4.

In compact technology of Valance OD, compact means______

a)

COMPRESSED ADDITION COMPACT TABLET

b)

COMPRESSED ADHESIVE COMPACT TABLET

c)

COMPRESSED ADDITIVE COMPACT TABLET

d)

COMPRESSED ADHERENCE COMPACT TABLET

5.

In Valance OD Compact, the tablet size is reduced by______

a)

18%

b)

81%

c)

49%

d)

20%

6.

18% size reduction in Valance OD Compact is bcoz of_________(multiple answers)

a)

Reducing 49% excipients

b)

Reducing 22% weight

c)

Reducing 48% excipients

d)

Reducing 20% Volume

7.

Size of divalproex tablets is large due to

a)

Hygroscopic molecule hence more excipients

to maintain release profile

b)

Hydrophobic molecule hence ore excipients

to maintain release profile

c)

Hydro molecule hence more excipients

to maintain release profile

d)

None of the above

8.

Valance OD Compact 18% size reduction is done (multiple answer)

a)

Without altering the release pattern

b)

With dissolution profile as per standard method

c)

With altering the release pattern

d)

With dissolution profile not as per standard method

9.

Valance OD compact tablet is available in

a)

7s tablet/strip

b)

10s tablet/strip

c)

15s tablet/strip

d)

30s tablet/strip

10.

The punch line of Valance OD compact is

a)

Make life easy

b)

Life is easy

c)

Swallowing made easy

d)

Life made easy

11.

Identify the Valance OD Compact tablet in the pic

a)

1

b)

2

c)

3

d)

4

12.

Valance OD compact tablet is

a)

Slightly larger than US FDA recommended size

b)

Smaller than US FDA recommended size

c)

Equal to US FDA recommended size

d)

None of the above

13.

US FDA recommended tablet size is

a)

Should not be more than 28 mm

b)

Should not be more than 26 mm

c)

Should not be more than 22 mm

d)

Should not be more than 18 mm

14.

Valance OD Compact tablet dissolution profile

a)

is different compared to standard methods

b)

is similar compared to standard methods

c)

Varies compared to standard methods

d)

None of the above

15.

As per VAF : 7 out of 10 patients find Valproate Tablets comfortable to swallow

a)

True

b)

False

16.

Complete as per VAF

a)

tablet gets dissolved completely

b)

Tablet remains same as taken

c)

Swells without getting dissolved

d)

Initial wetting leads to formation of gel & tablet swelling

17.

Individuals who find it difficult to swallows the tablet frequently cite the_____________reason for swallowing difficulty

a)

color of the tablet as major

b)

Packing as the major

c)

the size as major

d)

None of the above

18.

__________ & _________ of the tablet affect the transits of product through pharynx & esophagus

a)

Size & Color

b)

Shape & Color

c)

Size & Shape

d)

None of the above

19.

As per the graph shown in VAF, % dissolution of Valance OD compact tablet in 24 hrs is ____.

a)

61%

b)

75%

c)

96%

d)

100%

20.

Divalproex in Valance OD compact is homogeneously dispersed throughout polymer network which serves

a)

release rate reversal

b)

release rate retardant

c)

release rate resistant

d)

None of the above